Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Equity
$388m
CAGR 3-Years
9%
CAGR 5-Years
26%
CAGR 10-Years
23%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Equity
CA$19.4m
CAGR 3-Years
199%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Equity
-$19.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Total Equity
$212.1m
CAGR 3-Years
-10%
CAGR 5-Years
86%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Total Equity
CA$21.7m
CAGR 3-Years
34%
CAGR 5-Years
16%
CAGR 10-Years
13%
Spectral Medical Inc
TSX:EDT
Total Equity
-CA$31.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Total Equity?
Total Equity
388m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Total Equity amounts to 388m USD.

What is Aurinia Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 10Y
23%

Over the last year, the Total Equity growth was -1%. The average annual Total Equity growth rates for Aurinia Pharmaceuticals Inc have been 9% over the past three years , 26% over the past five years , and 23% over the past ten years .

Back to Top